|
PB 119 of 2022
Determinations/Health as made
|
|
The instrument amends the National Health (Pharmaceutical Benefits) (Pharmacist Substitution of Medicines without Prescription during Shortages) Determination 2021 by adding various forms of amoxicillin that are currently subject to a Therapeutic Goods Administration (TGA) Serious Scarcity Substitution Instrument (SSSI). This allows supplies made under the TGA SSSI to be Pharmaceutical Benefits Scheme subsidised.
|
|
Administered by: Health and Aged Care
|